Barriers to HIV testing as reported by individuals newly diagnosed with HIV infection in Sweden

References

• Brännström, J., Johansson, V., Marrone, G., Wendahl, S., Yilmaz, A., & Sönnerborg, A. (2016). Deficiencies in the health care system contribute to a high rate of late HIV diagnosis in Sweden. HIV Medicine, 17(6), 425–435. https://doi.org/10.1111/hiv.12321
   PubMed Web of Science ®Google Scholar
• Brännström, J., Sönnerborg, A., Svedhem, V., Neogi, U., & Marrone, G. (2017). A high rate of HIV-1 acquisition post immigration among migrants in Sweden determined by a CD4 T-cell decline trajectory model. HIV Medicine. https://doi.org/10.1111/hiv.12509
   PubMed Web of Science ®Google Scholar
• Brännström, J. (2016). Assessment of patients with late diagnosis and missed opportunities in the Swedish HIV-1 epidemic. Karolinska Institutet. https://ki.primo.exlibrisgroup.com/permalink/46KIB_INST/11gg9h5/alma9973452302336
   Google Scholar
• Brännström, J., Svedhem, V., Marrone, G., Andersson, Ö, Azimi, F., Blaxhult, A., & Sönnerborg, A. (2016). Symptomatic patients without epidemiological indicators of HIV are at higher risk of missed diagnosis: A multicenter cross-sectional study. PLoS One, 11(9), 1–13. https://doi.org/10.1371/journal.pone.0162503
   Web of Science ®Google Scholar
• Croxford, S., Kitching, A., Desai, S., Kall, M., Edelstein, M., Skingsley, A., & Delpech, V. (2017). Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: An analysis of a national observational cohort. The Lancet. Public Health, 2(1), e35–e46. https://doi.org/10.1016/S2468-2667(16)30020-2
   PubMed Web of Science ®Google Scholar
• ECDC. (2017). Special Report, Continuum of HIV care: Monitoring implementation of the Dublin declaration on partnership to fight HIV/AIDS in Europe and Central Asia, 2017. http://ecdc.europa.eu/en/publications/Publications/Continuum-of-HIV-care-2017.pdf
   Google Scholar
• European Centre for Disease Prevention and Control/ WHO Regional Office for Europe. (2017). HIV/AIDS surveillance in Europe 2016. ECDC.
   Google Scholar
• Eurotest. (2014). Guidance for implementing HIV testing in adults in health care settings. https://www.eurotest.org/Portals/0/Documents/Guidance.pdf.pdf?ver=2014-01-29-113626-000
   Google Scholar
• Gardner, A. T., Napier, R., & Brown, B. (2016). Risk factors for “late-to-test” HIV diagnosis in Riverside County, California. Medicine, 95(39), e5021. https://doi.org/10.1097/MD.0000000000005021
   PubMed Web of Science ®Google Scholar
• Giardina, F., Romero-Severson, E. O., Axelsson, M., Svedhem, V., Leitner, T., Britton, T., & Albert, J. (2019). Getting more from heterogeneous HIV-1 surveillance data in a high immigration country: Estimation of incidence and undiagnosed population size using multiple biomarkers. International Journal of Epidemiology, 48(6), 1795–1803. https://doi.org/10.1093/ije/dyz100
   PubMed Web of Science ®Google Scholar
• Gisslén, M., Svedhem, V., Lindborg, L., Flamholc, L., Norrgren, H., Wendahl, S., & Sönnerborg, A. (2017). Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 continuum of HIV care targets. HIV Medicine, 18(4), 305–330. https://doi.org/10.1111/hiv.12431
   PubMed Web of Science ®Google Scholar
• Hallberg, D., Kimario, T. D., Mtuya, C., Msuya, M., & Björling, G. (2019). Factors affecting HIV disclosure among partners in Morongo, Tanzania. International Journal of Africa Nursing Sciences, 10, 49–54. https://doi.org/10.1016/j.ijans.2019.01.006
   Google Scholar
• Kannan, V., & Veazie, P. (2014). Predictors of avoiding medical care and reasons for avoidance behavior. Medical Care, 52(4), 336–345. https://doi.org/10.1097/MLR.000000000000010
   PubMed Web of Science ®Google Scholar
• Kendrick, H. (2017). Are religion and spirituality barriers or facilitators to treatment for HIV: A systematic review of the literature. AIDS Care, 29(1), 1–13. https://doi.org/10.1080/09540121.2016.1201196
   PubMed Web of Science ®Google Scholar
• Montoy, J. C. C., Dow, W. H., & Kaplan, B. C. (2016). Patient choice in opt-in, active choice, and opt-out HIV screening: Randomized clinical trial. BMJ, 352, h6895. https://doi.org/10.1136/bmj.h6895
   Google Scholar
• Public Health Agency of Sweden. (2015). Beräkning av mörkertalet bland personer som lever med hivinfektion i Sverige. https://www.folkhalsomyndigheten.se/documents/smittskydd-sjukdomar/hivprevention-sexuell-halsa/hiv-morkertal.pdf?epslanguage=sv
   Google Scholar
• Public Health Agency of Sweden. (2017). https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/statistikdatabaser-och-visualisering/sjukdomsstatistik/hivinfektion/
   Google Scholar
• QRC Stockholm. (2020). Retrieved October 9, 2020. https://qrcstockholm.se/wp-content/uploads/2020/10/Arsrapport-InfCareHIV-2019.pdf
   Google Scholar
• Schwarcz, S., Richards, T. A., Frank, H., Wenzel, C., Chin Hsu, L., Chin, C. S. J., & Dilley, J. (2011). Identifying barriers to HIV testing: Personal and contextual factors associated with late HIV testing. AIDS Care, 23(7), 892–900. https://doi.org/10.1080/09540121.2010.534436
   PubMed Web of Science ®Google Scholar
• Vaismoradi, M., Turunen, H., & Bondas, T. Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study. Nursing & Health Sciences, 15(3), 398–405. 10.1111/nhs.12048.
   Google Scholar
• Wiklander, M., Brännström, J., Svedhem, V., & Eriksson, L. E. (2015). Development and psychometric testing of a barriers to HIV testing scale among individuals with HIV infection in Sweden; The barriers to HIV testing scale-Karolinska version. Health and Quality of Life Outcomes, 13(1), 185. https://doi.org/10.1186/s12955-015-0381-7
   PubMedGoogle Scholar
• World Health Organization. (2015). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. In Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV.
   Google Scholar